NOVYRA PHARMACHEM LIMITED Share Price

NOVYRA PHARMACHEM LIMITED Share Price

BSE: 519353
|
Tea/Coffee
|
S Cap
₹ 10.67
+0.00 (0.00%)
1D
Last updated 31 Aug, 2026, 14:49 IST
--
0.00% up today
--
1D LOW
1D HIGH

NOVYRA PHARMACHEM LIMITED Returns Calculator

Circuit
L
H
₹10.14
₹11.20
52-week
L
H
₹5.88
₹16.55

About NOVYRA PHARMACHEM LIMITED

NOVYRA PHARMACHEM LIMITED Share Price
ISIN
INE856E01019
Sector Market Cap
₹ 6.75 Cr

Bansisons Tea Industries Limited is an India-based company. The Company is engaged in tea plantation, production and marketing.

NOVYRA PHARMACHEM LIMITED Financial Highlights

  • Revenue: NOVYRA PHARMACHEM LIMITED reported revenue of ₹0.16 crore in FY26 vs ₹0.05 crore in FY25. It showed an increase of 220.00% on a yearly basis.
  • Operating Profit: NOVYRA PHARMACHEM LIMITED reported an operating loss of ₹5.37 crore in FY26 vs ₹0.06 crore in FY25. It showed a decrease of 8,850.00% on a year-on-year basis.
  • Net Profit: NOVYRA PHARMACHEM LIMITED reported a net loss of ₹5.37 crore in FY26 vs ₹0.06 crore in FY25. It showed a decrease of 8,850.00% on a yearly basis.

NOVYRA PHARMACHEM LIMITED Quarterly Result Highlights

  • NOVYRA PHARMACHEM LIMITED reported revenue of ₹1.73 crore in Jun 2026, compared with ₹0.10 crore in Mar 2026, representing an increase of 1,630.00% on a quarter-on-quarter (QoQ) basis.
  • NOVYRA PHARMACHEM LIMITED reported an operating loss of ₹0.02 crore in Jun 2026, compared with ₹5.34 crore in Mar 2026, representing an increase of 99.63% on a quarter-on-quarter (QoQ) basis.
  • NOVYRA PHARMACHEM LIMITED reported a loss of ₹0.02 crore in Jun 2026, compared with ₹5.34 crore in Mar 2026, reflecting an increase of 99.63% on a QoQ basis.
  • The earnings per share (EPS) of NOVYRA PHARMACHEM LIMITED stood at ₹8.49 during Jun 2026.
Know more
Promoters
23.15%
FII
0.00%
Other DII
0.00%
Retail and other
76.85%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
6.75
P/E
-1.26
P/B
10.86
ROE
-907.58%
D/E
0.00
ROCE
-907.58%
Div. Yield
0.00%
EPS(TTM)
-8.49
Turnover
1.25
EV/EBITDA
-1.23
Net Margin
-5,370.00%
Op. Margin
-5,340.00%
ROA
-368.49%
Quick Ratio
0.86
Curr. Ratio
0.83
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
NOVYRA PHARMACHEM outperforming most market indices
Step 1 of 5
Valuation
Overvalued
NOVYRA PHARMACHEM appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
CCL Products14,690.7033.476.1716.55%0.4516.07%103.130.53%0.8821.56
Pix Transmissions2,417.3518.343.4715.34%0.0420.41%466.630.51%0.7267.58
TINNA RUBBER AND INFR LTD1,839.0529.826.1217.59%0.4419.28%162.700.32%1.0829.90
GRP1,081.09190.696.062.12%1.046.28%361.270.17%1.3016.74
International Conveyors508.273.731.2016.11%0.1819.40%66.430.63%0.3710.72
McLeod Russel India506.09-5.260.00-43.86%-10.29-4.42%-35.480.00%0.49-8.70
RUBFILA INTERNATIONAL LTD371.3013.971.148.13%0.0011.39%54.673.02%1.445.01
Harrison Malayalam354.0612.911.9616.31%0.6214.42%96.800.00%1.0915.80
GAYATRI RUBB AND CHEM LTD338.54———0.00—0.000.00%2.069.74
Elgi Rubber Co.303.91-1.544.03-113.56%0.98-13.93%38.880.00%0.58-22.97

NOVYRA PHARMACHEM LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.10₹0.00₹0.00₹0.15
Other Income₹0.06₹0.05₹0.00₹0.01
Total Revenue₹0.17₹0.05₹0.00₹0.16
Total Expenses₹5.54₹0.11₹0.16₹0.12
Profit Before Tax-₹5.37-₹0.06-₹0.16₹0.03
Tax₹0.00₹0.00₹0.00₹0.02
Profit After Tax-₹5.37-₹0.06-₹0.16₹0.01
EPS - Basic-₹8.49-₹0.10-₹0.26₹0.02
EPS - Diluted-₹8.49-₹0.10-₹0.26₹0.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹5.37-₹0.06-₹0.16₹0.03
Income before WC changes-₹5.41-₹0.08-₹0.14₹0.05
Change in Assets₹0.78₹0.06-₹0.03₹0.10
Change in Liabilities₹0.84-₹0.27₹0.04₹0.02
Change in WC₹1.62-₹0.21₹0.00₹0.11
Cash flow from Operations-₹3.79-₹0.28-₹0.14₹0.14
Cash flow from Investing₹3.85₹0.08₹0.00₹0.01
Cash flow from Financing-₹0.15₹0.28₹0.00₹0.00
Total Cash Flow-₹0.09₹0.08-₹0.14₹0.14
Cash (Start of the year)₹0.26₹0.09₹0.22₹0.08
Cash (End of the year)₹0.18₹0.26₹0.09₹0.22

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹0.74₹5.85₹5.89₹5.87
Current Assets₹0.75₹0.30₹0.23₹0.37
Total Assets₹1.49₹6.14₹6.12₹6.24
Current Liabilities₹0.87₹0.18₹0.09₹0.06
Net Current Asset-₹0.12₹0.12₹0.14₹0.31
Non-Current Liabilities₹0.00₹0.00₹0.10₹0.10
Equity Capital₹0.62₹5.97₹5.93₹6.09
Total Equity & Liabilities₹1.49₹6.14₹6.12₹6.24
* All values are in INR Crore
Qty
Bid
100
10.67
200
10.14
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 300
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
62.34
Neutral
ATR (14)
0.32
Neutral
STOCH(9,6)
42.37
Neutral
STOCH RSI (14)
19.33
Bullish
ADX(9)
56.37
Bearish
UO(9)
41.43
Neutral
ROC(12)
-1.48
Bearish
WillR(14)
-71.59
Neutral
Period
Simple value
Exponential vaue
5D
10.47
10.62
10D
10.66
10.83
20D
11.49
11.53
50D
13.43
11.47
100D
12.27
0
Volume trend — traded volume by day
31 Aug0L
Average0L
Compare against other stocks
NOVYRA PHARMACHEM LIMITED Share Price
NOVYRA PHARMACHEM LIMITED
Tea/Coffee
Add Stock
Add Another

NOVYRA PHARMACHEM LIMITED Share Price FAQs